American Pain Society, Principles of analgesic use in the treatment of acute pain and cancer pain: a concise guide to medical practice, Skokie, IL, American Pain Society; 1992.

Bonica JJ, The Management of Pain, 2nd Ed., Lea and Febiger, Philadelphia, 1990.

Bruera E, Brenneis C, Patterson AH, Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer, J Pain and Symptom Management, 1989; 4(l):3-6.

Campora E, Merlini L, Pace M, et al, The incidence of narcotic-induced emesis, J Pain and Symptom Management, 1991; 6:428-30.

Cancer Pain Relief, 2nd Ed, World Health Organization, Geneva, 1996.

Chapman CR, Hill HF, Prolonged morphine self-administration and addiction liability, Cancer,1989; 63:1636-44.

Cherny NI, Portenoy RK, Cancer pain management: current strategy, Cancer (Supplement), 1993; 72:3394-3415.

Foley KM, Controversies in cancer pain: medical perspective, Cancer, 1989; 63:2257-65.

Foley KM, Pain syndromes in Patients with Cancer, Medical Clinics of No. America, 71(2): 169-184; 1987

Foley KM, The treatment of cancer pain, NEJM, 1985a: 313(2):84-95.

Hester NO, Barcus CS, Assessment and management of pain in children, Pediatric: Nurs Update, 1986; 1:18.

Houde RW, Analgesic effectiveness of the narcotic agonist-antagonists, Br J Clin Pharmacology, 1979; 7:297S-308S.

Jaycox A, Carr DB, Payne R, et al. Management of Cancer Pain, Clinical Practice Guideline No. 9, Agency for Health Care Policy and Research, US Department of Health and Human Services, 1994.

Kaiki RK, Foley KM, Intrussi CE, et al, Central nervous system excitatory effects of meperidine in cancer patients, Ann Neurol, 1983; 13:180-5. 28 i.b.i.d. ref. 1, p. 88.

Levy MH, Pharmacological treatment of cancer pain, NEJM, 1996; 335(15):1124-1132.

Mayer DJ, Mao J, Price DD, The development of morphine tolerance and dependence is associated with the translocation of protein kinase C, Pain, 1995; 61:365-74.

Pirson Y, van Ypersele de Strihou C, Renal side effects of nonsteriodal anti-inflammatory drugs: clinical relevance, Am J Kidney Dis, 1986; 8:337-344.

Portenoy RK, Hagen NA, Breakthrough pain: definition, prevalence, and characteristics, Pain, 1990; 41:273-81.

Portenoy RK, Opioid analgesics, in Portenoy RK, Kanner RM, Pain Management: Theory and Practice, FA Davis & Co, Philadelphia, 1996.

Reisine T, Pasternak G, Opioid analgesics and antagonists, in Hardman JG, Limbird LE, eds., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th Ed., Pergamon Press, New York,1996, Chap 23.

Schuster CR, Does treatment of cancer pain with narcotics produce junkies?in Hill CS, Fields WS, Drug treatment of cancer pain in a drug oriented society: advances in pain research and therapy, Vol 11, Raven Press, New York, 10989, ppl-3

Seef Lb, Cucchierini BA, Zimmerman Hl, Benjamin S, Acetaminophen hepatotoxicity in alcoholics, Ann Int Med, 1986; 104:339-404.

Twycross RG, Clinical Experience with Diamorphine in Advanced Malignant Pain, Int Journal of Clinical Pharmacology, 1974; 9:184-198

Walsh TD, Prevention of opioid side effects, J Pain and Symptom Management, 1990; 5:363-7.